Extrapyramidal and cerebellar movement disorder in association with heterozygous ceruloplasmin gene mutation [6]

Journal of Neurology

Volumn 252, Issue 1, 2005, Pages 111-113

  Kuhn, Jens ^a   Miyajima, Hiroaki ^b   Takahashi, Yoshitomo ^b   Kunath, Bernhard ^c   Hartmann Klosterkoetter, Ursula ^a   Cooper Mahkorn, Déirdre ^a   Schaefer, Mark ^d   Bewermeyer, Heiko ^a  

^a KRANKENHAUS MERHEIM   (Germany)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; DEFEROXAMINE; PENICILLAMINE;

ACERULOPLASMINEMIA; ADOLESCENT; ATAXIA; CASE REPORT; CEREBELLUM DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC PROCEDURE; EXTRAPYRAMIDAL SYNDROME; FEMALE; GENE MUTATION; HUMAN; HYPERKINESIA; LABORATORY TEST; LETTER; LIVER BIOPSY; MOTOR DYSFUNCTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETINA DEGENERATION; WILSON DISEASE;

ADOLESCENT; BASAL GANGLIA DISEASES; BRAIN; CEREBELLAR DISEASES; CERULOPLASMIN; COPPER; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; ELECTROENCEPHALOGRAPHY; FAMILY HEALTH; FEMALE; HEPATOLENTICULAR DEGENERATION; HETEROZYGOTE; HUMANS; IRON METABOLISM DISORDERS; LIVER; MUTATION; MUTATION, MISSENSE; NEURODEGENERATIVE DISEASES; POSITRON-EMISSION TOMOGRAPHY;

EID: 13144261730     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-005-0608-3     Document Type: Letter

References (13)

1. Daimon M, Moriai S, Susa S, Yamatani K, Hosoya T, Kato T (1999) Hypocaeruloplasminaemia with heteroallelic caeruloplasmin gene mutation: MRI of the brain. Neuroradiology 41:185-187
2. Daimon M, Susa S, Ohizumi, T, Moriai S, Kawanami T, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Kato T (2000) A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (HypoCPGM). Tohoku J Exp Med 191:119-125
3. Harris ZL, Durley AP, Man TK, Gitlin JD (1999) Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci U S A 96:10812-10817
4. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD (1995) Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 92:2539-2543
5. Klomp LW, Farhangrazi ZS, Dugan LL, Gitlin JD (1996) Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest 98:207-215
6. Kohno S, Miyajima H, Takahashi Y, Inoue Y (2000) Aceruloplasminemia with a novel mutation associated with parkinsonism. Neurogenetics 2: 237-238
7. Miyajima H, Kono S, Takahashi Y, Sugimoto M, Sakamoto M, Sakai N (2001) Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 57:2205-2210
8. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N (1987) Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37:761-767
9. Miyajima H, Takahashi Y, Kamata T, Shimizu H, Sakai N, Gitlin JD (1997) Use of desferrioxamine in the treatment of aceruloplasminemia. Ann Neurol 41:404-407
10. Miyajima H, Takahashi Y, Kono S, Sugimoto M, Suzuki Y, Hishida A, Sakamoto M, Ouchi Y (2002) Glucose and oxygen hypometabolism in aceruloplasminemia brains. Intern Med 41:186-190
11. Morita H, Ikeda S, Yamamoto K, Morita S, Yoshida K, Nomoto S, Kato M, Yanagisawa N (1995) Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 37:646-656
12. Patel BN, Dunn RJ, Jeong SY, Zhu Q, Julien JP, David S (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 22:6578-6586
13. Schosinsky KH, Lehmann HP, Beeler MF (1974) Measurement of ceruloplasmin from ist oxidase activity in serum by o-dianisidine dihydrochloride. Clin Chem 20:1556-1563